INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Kyndryl Holdings, Inc. – KD

(NYSE:KD), NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Kyndryl and certain of its officers and/or directors have […]

Zenas BioPharma, Inc. Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against ZBIO

(NASDAQ:ZBIO), SAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) — Robbins LLP reminds stockholders that a class action was filed on behalf of all persons who purchased or otherwise acquired Zenas BioPharma, Inc. (NASDAQ: ZBIO) securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Zenas BioPharma's September 2024 initial public

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Kyndryl Holdings, Inc. – KD

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Kyndryl Holdings, Inc. – KD GlobeNewswire April 21, 2025 NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD). Such investors are advised to contact Danielle

Zenas BioPharma, Inc. Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against ZBIO

Zenas BioPharma, Inc. Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against ZBIO GlobeNewswire April 21, 2025 SAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) — Robbins LLP reminds stockholders that a class action was filed on behalf of all persons who purchased or otherwise acquired Zenas BioPharma, Inc. (NASDAQ: ZBIO) securities pursuant

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Movado Group, Inc. – MOV

(NYSE:MOV), NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Movado Group, Inc. (“Movado” or the “Company”) (NYSE: MOV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Movado and certain of its officers and/or directors have

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Movado Group, Inc. – MOV

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Movado Group, Inc. – MOV GlobeNewswire April 21, 2025 NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Movado Group, Inc. (“Movado” or the “Company”) (NYSE: MOV). Such investors are advised to contact Danielle

SWKS Investors Have Opportunity to Lead Skyworks Solutions, Inc. Securities Fraud Lawsuit

https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities ofSkyworks Solutions, Inc. (NASDAQ: SWKS) between July 30, 2024 and February 5, 2025, both dates inclusive (the “Class Period”), of the important May 5, 2025 lead plaintiff deadline. So what: If you purchased Skyworks securities during the Class Period you

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CarMax, Inc. – KMX

(NYSE:KMX), NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of CarMax, Inc. (“CarMax” or the “Company”) (NYSE: KMX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether CarMax and certain of its officers and/or directors have engaged

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. – TMCI

(NASDAQ:TMCI), NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Treace Medical and certain of its officers

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CarMax, Inc. – KMX

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CarMax, Inc. – KMX GlobeNewswire April 21, 2025 NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of CarMax, Inc. (“CarMax” or the “Company”) (NYSE: KMX). Such investors are advised to contact Danielle Peyton at

Scroll to Top